The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers

The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers

Background: Following the announcement of actress Angelina Jolie’s prophylactic bilateral mastectomies and subsequent prophylactic oophorectomy, there has been a dramatic increase in interest in BRCA testing and prophylactic surgery. Objective: To review current medical literature on the benefits...

Full description

Bibliographic Details
Main Author:	Sharon Galper Grossman
Format:	Article
Language:	English
Published:	Rambam Health Care Campus 2015-10-01
Series:	Rambam Maimonides Medical Journal
Subjects:	BRCA prophylactic surgery Jewish law
Online Access:	http://rmmj.org.il/userimages/499/1/PublishFiles/524Article.pdf

Similar Items

Angelina′s choice
by: Nishu Singh Goel
Published: (2013-01-01)

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
by: Janusz Menkiszak, et al.
Published: (2019-03-01)

Oncological Safety of Lipofilling in Healthy BRCA Carriers After Bilateral Prophylactic Mastectomy: A Case Series
by: Christophe Ho Quoc, et al.
Published: (2019-10-01)

Carrier screening program for BRCA1/BRCA2 pathogenic variants among Ashkenazi Jewish women in Israel: An observational study
by: Rotem Greenberg, et al.
Published: (2023-01-01)

Vape Gods and Judaism—E-cigarettes and Jewish Law
by: Sharon Galper Grossman
Published: (2019-07-01)

Risk-Reducing Mastectomy and Reconstruction Following Prophylactic Breast Irradiation: Hope Sustained
by: Merav A. Ben David, et al.
Published: (2021-05-01)

Prophylactic Surgery in the BRCA+ Patient: Do Women Develop Breast Cancer While Waiting?
by: Sheina A. Macadam, et al.
Published: (2021-01-01)

Prophylactic mastectomy for the prevention of breast cancer: Review of the literature
by: Rawan K. Alaofi, et al.
Published: (2018-07-01)

Evaluation of the indication of BRCA1/2 genetic tests in Iranian women and acceptance rate of risk‐reducing surgeries in BRCA mutation carriers
by: Mahtab Vasigh, et al.
Published: (2022-02-01)

Cancer Anxiety Mediates the Association Between Satisfaction With Medical Communication and Psychological Quality of Life After Prophylactic Bilateral Salpingo-Oophorectomy
by: Cristina Zarbo, et al.
Published: (2022-03-01)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
by: Angela R. Solano, et al.
Published: (2018-08-01)

High-Grade Serous Tumor Arising from Fallopian Tube in a BRCA Mutation Carrier after Prophylactic Oophorectomy
by: Domenica Lorusso, et al.
Published: (2013-01-01)

Developments in Clinical Practice: Follow up Clinic for BRCA Mutation Carriers: a Case Study Highlighting the "Virtual Clinic"
by: Ardern-Jones Audrey, et al.
Published: (2004-02-01)

Mass Spectrometry-based Serum Proteome Pattern Analysis in Prophylactic Oophorectomy
by: Lukkana Promwattanaphan, et al.
Published: (2015-12-01)

Effect of risk-reducing salpingo-oophorectomy on the quality of life in Korean BRCA mutation carriers
by: Sumin Chae, et al.
Published: (2021-08-01)

Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type
by: Andrew Berchuck, et al.
Published: (2015-04-01)

Perceptions of Prophylactic Mastectomy in Korea
by: Han Young Yoon, et al.
Published: (2016-01-01)

Body Image in BRCA-Positive Young Women Following Bilateral Risk-Reducing Mastectomy: A Review of the Literature
by: Christa Torrisi
Published: (2021-12-01)

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis
by: Merav A. Ben-David, et al.
Published: (2020-02-01)

Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014-07-01)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
by: Michael G. Schrauder, et al.
Published: (2019-09-01)

Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation
by: Victoria Teoh, et al.
Published: (2020-01-01)

The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer
by: Narendra Nath Basu, et al.
Published: (2021-02-01)

Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis
by: Ziqi Jia, et al.
Published: (2021-09-01)

Response to “Letter to the Editor Regarding Vaping.” Seven Reasons E-cigarettes Must Be “Downright Prohibited” Now!
by: Sharon Galper Grossman
Published: (2019-10-01)

Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
by: McKinley Joanne M, et al.
Published: (2007-09-01)

Risk-Reducing Salpingo-Oophorectomy (RRSO) Combined with Simultaneous Mastectomy in Women with BRCA 1–2 Mutation Carriers: The Surgical Technique, the Feasibility and Patients’ Satisfaction of Multiple Surgeries
by: Carlo Saccardi, et al.
Published: (2022-12-01)

¿SE JUSTIFICA LA OOFORECTOMÍA, COMO MEDIDA PROFILÁCTICA EN LA DISMINUCIÓN DEL RIESGO DE CÁNCER DE OVARIO Y DE MAMA, EN LAS PACIENTES PORTADORAS DE MUTACIONES EN LOS GENES BRCA1 O BRCA2?
by: Marcelo González V, et al.
Published: (2004-01-01)

Theory‐based behavior change intervention to increase uptake of risk‐reducing salpingo‐oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial
by: Kelly A. Metcalfe, et al.
Published: (2023-09-01)

Contralateral prophylactic mastectomy: current perspectives
by: Yao K, et al.
Published: (2016-06-01)

Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers
by: Giovanni Paolino, et al.
Published: (2022-04-01)

Bilateral prophylactic mastectomy as an option for prevention of contralateral breast cancer
by: D. V. Pominchuk, et al.
Published: (2020-11-01)

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
by: M.G. Davey, et al.
Published: (2021-04-01)

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery
by: Wen Yee Chay, et al.
Published: (2015-04-01)

Founder mutations in <it>BRCA1/2 </it>are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
by: Kotar Kimberley, et al.
Published: (2003-08-01)

What is Jewish in Jewish philosophy?
by: Karl-Johan Illman
Published: (2000-09-01)

Role of Sentinel Lymph Node Biopsy During Contralateral Prophylactic Mastectomy
by: Halil Kara, et al.
Published: (2020-03-01)

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer
by: Renan Gomes, et al.

Jewish Education and Jewish Identity in the Post-modern Era
by: Zehavit Gross
Published: (2017-04-01)

Risk of metastasis in BRCA2 carriers diagnosed with triple‐negative breast cancer
by: Marcelo Moreno, et al.
Published: (2023-08-01)